Awarded
NHS Pharmaceuticals 2017_2
Descriptions
Invitation to offer for NHS Pharmaceuticals 2017_2.Offer reference number: CM/PHG/15/5491.Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months.Potential periods of call-offs under the framework agreement:CESW: 1.8.2018 to 28.2.2019 (7 months),NWLN: 1.8.2018 to 31.7.2019 (12 months),LSNE: 1.8.2018 to 31.1.2020 (18 months).Products on the framework include (but are not necessarily limited to): Abacavir, Abiraterone, Anidulafungin, Atovaquone, Bosentan, Ciclesonide, Drospirenone / Ethinylestradiol, Enfurvitide, Ethinylestradiol / Norelgestromin, Exenatide, Ezetimibe, Iloprost, Ivabradine, Mycophenolic acid, Nitisinone, Olopatadine, Oseltamivir, Parecoxib, Pegfilgrastim, Pegvisomant, Pregabalin, Tadalafil, Tenofovir, Tigecycline, Valproic acid, Velaglucerase. Details of presentation sizes and volumes are within the tender document set.
Timeline
Published Date :
Deadline :
Tender Awarded :
Awarded date :
Contract Start :
Contract End :
Tender Regions
CPV Codes
33690000 - Various medicinal products
33600000 - Pharmaceutical products
Workflows
Status :
Assign to :
Tender Progress :
Details
Notice Type :
Tender Identifier :
TenderBase ID :
Low Value :
High Value :
Region :
Attachments :
Buyer Information
Address :
Website :
Procurement Contact
Name :
Designation :
Phone :
Email :
Possible Competitors
1 Possible Competitors
